This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceuticalcompanies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape.
Delayed clinical trial data delivery is a growing problem for pharmaceuticalcompanies and one that can have catastrophic consequences for the development of their promising pipeline candidates. The pharmaceutical industry faces continual pressure to optimise clinical trials, maximise returns and minimise risk.
As computing has developed in the past decade, so has the potential to store and use information in the cloud. Fresenius Kabi is a global healthcare company specialising in medicines and technologies for infusion, transfusion and clinical nutrition. In 2020, Fresenius Kabi introduced their first RFID-enabled medication, Diprivan +RFID.
Pharmaceuticalcompanies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. These database transfer activities must follow industry standards and pharmacovigilance regulation, which has become increasingly stringent over the last decade.
This article provides an informative account of intelligent automation, the key differences between AI & ML, their importance, and a potent eight-step roadmap to implementation. Covering all the AI-based pharmaceuticalcompanies is beyond the scope of this article. With the impelling Pharma 4.0,
It is a critical aspect of any organization, as data integrity makes data valuable, enables informed decision-making, and ensures adherence to life sciences and pharmaceutical regulations. Proof of data quality Data integrity is a direct reflection of data quality.
But before pharmaceuticalcompanies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. AI also helps in interactions with patients, as it can be used for automating patient recruitment and data collection.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content